{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:35:18Z","timestamp":1786980918356,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T00:00:00Z","timestamp":1596844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s10620-020-06509-7","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T13:02:56Z","timestamp":1596891776000},"page":"2323-2335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Systematic Review and Meta-Analyses Assessment of the Clinical Efficacy of Bismuth Subsalicylate for Prevention and Treatment of Infectious Diarrhea"],"prefix":"10.1007","volume":"66","author":[{"given":"Jose M.","family":"Brum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger D.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guhan","family":"Balan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3472-6697","authenticated-orcid":false,"given":"Bruce R.","family":"Yacyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,8]]},"reference":[{"key":"6509_CR1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0924-8579(99)00149-1","volume":"14","author":"MJ Farthing","year":"2000","unstructured":"Farthing MJ. Diarrhea: a significant worldwide problem. Int J Antimicrob Agents. 2000;14:65\u201369.","journal-title":"Int J Antimicrob Agents"},{"key":"6509_CR2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3201\/eid1701.P21101","volume":"17","author":"E Scallan","year":"2011","unstructured":"Scallan E, Griffin PM, Angulo FJ, et al. Foodborne illness acquired in the United States\u2014unspecified agents. Emerg Infect Dis. 2011;17:16\u201322.","journal-title":"Emerg Infect Dis"},{"key":"6509_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2008.10.009","volume":"44","author":"MM Patel","year":"2009","unstructured":"Patel MM, Hall AJ, Vinje J, Parashar UD. Noroviruses: a comprehensive review. J Clin Virol. 2009;44:1\u20138.","journal-title":"J Clin Virol"},{"key":"6509_CR4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cid\/cir478","volume":"53","author":"C Yen","year":"2010","unstructured":"Yen C, Wikswo ME, Lopman BA, et al. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis. 2010;53:568\u2013571.","journal-title":"Clin Infect Dis"},{"key":"6509_CR5","unstructured":"CDC. National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Foodborne, Waterborne, and Environmental Diseases (DFWED). Last updated July 15, 2016. https:\/\/www.cdc.gov\/foodborneburden\/2011-foodborne-estimates.html."},{"key":"6509_CR6","doi-asserted-by":"crossref","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459\u20131544.","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"6509_CR7","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","volume":"19","author":"AJ Hall","year":"2013","unstructured":"Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerg Infect Dis. 2013;19:1198\u20131205.","journal-title":"Emerg Infect Dis"},{"key":"6509_CR8","unstructured":"CDC. Vessel Sanitation Program. Centers for Disease Control and Prevention: Norovirus. http:\/\/www.cdc.gov\/nceh\/vsp\/default.htm."},{"key":"6509_CR9","volume-title":"Chapter 2, The pre-travel consultation, self-treatable conditions: travelers\u2019 diarrhea","author":"BA Connor","year":"2016","unstructured":"Connor BA. CDC Health Information for International Travel 2016: the yellow book. In: Brunette GW, ed. Chapter 2, The pre-travel consultation, self-treatable conditions: travelers\u2019 diarrhea. New York, NY: Oxford University Press; 2016."},{"key":"6509_CR10","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/clinids\/12.Supplement_1.S11","volume":"12","author":"MD Manhart","year":"1990","unstructured":"Manhart MD. In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev Infect Dis. 1990;12:S11\u2013S15.","journal-title":"Rev Infect Dis"},{"key":"6509_CR11","first-page":"S41","volume":"4","author":"H Menge","year":"1992","unstructured":"Menge H, Gregor M, Brosius B, et al. Pharmacology of bismuth. Eur J Gastroenterol Hepatol. 1992;4:S41\u2013S47.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6509_CR12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF01648907","volume":"68","author":"R Raedsch","year":"1990","unstructured":"Raedsch R, Walter-Sack I, Weber E, Blessing J. Pharmacokinetics of bismuth preparations in patients with gastritis and ulcer disease. Klin Wochenschr. 1990;68:488.","journal-title":"Klin Wochenschr"},{"key":"6509_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/19490976.2015.1008336","volume":"6","author":"AM Pitz","year":"2015","unstructured":"Pitz AM, Park GW, Lee D, et al. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut Microbes. 2015;6:93\u2013100.","journal-title":"Gut Microbes"},{"key":"6509_CR14","first-page":"131","volume":"181","author":"DW Gump","year":"1992","unstructured":"Gump DW, Nadeau OW, Hendricks GM, Meyer DH. Evidence that bismuth salts reduce invasion of epithelial cells by enteroinvasive bacteria. Med Microbiol Immunol. 1992;181:131\u2013143.","journal-title":"Med Microbiol Immunol"},{"key":"6509_CR15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00202054","volume":"181","author":"OW Nadeau","year":"1992","unstructured":"Nadeau OW, Gump DW, Hendricks GM, Meyer DH. Deposition of bismuth by Yersinia enterocolitica. Med Microbiol Immunol. 1992;181:145\u2013152.","journal-title":"Med Microbiol Immunol"},{"key":"6509_CR16","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1128\/AAC.33.12.2075","volume":"33","author":"TE Sox","year":"1989","unstructured":"Sox TE, Olson CA. Binding and killing of bacteria by bismuth subsalicylate. Antimicrob Agents Chemother. 1989;33:2075\u20132082.","journal-title":"Antimicrob Agents Chemother"},{"key":"6509_CR17","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/clinids\/12.Supplement_1.S9","volume":"12","author":"NA Cornick","year":"1990","unstructured":"Cornick NA, Silva M, Gorbach SL. In vitro antibacterial activity of bismuth subsalicylate. Rev Infect Dis. 1990;12:S9\u2013S10.","journal-title":"Rev Infect Dis"},{"key":"6509_CR18","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1093\/clinids\/12.Supplement_1.S21","volume":"12","author":"SL Gorbach","year":"1990","unstructured":"Gorbach SL, Cornick NA, Silva M. Effect of bismuth subsalicylate on fecal microflora. Rev Infect Dis. 1990;12:S21\u2013S23.","journal-title":"Rev Infect Dis"},{"key":"6509_CR19","first-page":"1962","volume":"92","author":"HL DuPont","year":"1997","unstructured":"DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1997;92:1962\u20131975.","journal-title":"Am J Gastroenterol"},{"key":"6509_CR20","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1177\/106002808702100901","volume":"21","author":"HL DuPont","year":"1987","unstructured":"DuPont HL. Bismuth subsalicylate in the treatment and prevention of diarrheal disease. Drug Intell Clin Pharm. 1987;21:687\u2013693.","journal-title":"Drug Intell Clin Pharm"},{"key":"6509_CR21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.1980.03300290019013","volume":"243","author":"HL DuPont","year":"1980","unstructured":"DuPont HL, Sullivan P, Evans DG, et al. Prevention of traveler\u2019s diarrhea (emporiatric enteritis). Prophylactic administration of subsalicylate bismuth. JAMA. 1980;243:237\u2013241.","journal-title":"JAMA"},{"key":"6509_CR22","first-page":"871","volume":"80","author":"JD Gryboski","year":"1985","unstructured":"Gryboski JD, Hillemeier AC, Grill B, Kocoshis S. Bismuth subsalicylate in the treatment of chronic diarrhea of childhood. Am J Gastroenterol. 1985;80:871\u2013876.","journal-title":"Am J Gastroenterol"},{"key":"6509_CR23","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0016-5085(19)30507-4","volume":"78","author":"MC Steinhoff","year":"1980","unstructured":"Steinhoff MC, Douglas RG Jr, Greenberg HB, Callahan DR. Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology. 1980;78:1495\u20131499.","journal-title":"Gastroenterology"},{"key":"6509_CR24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/AAC.29.4.625","volume":"29","author":"R Steffen","year":"1986","unstructured":"Steffen R, Dupont HL, Heusser R, et al. Prevention of traveler\u2019s diarrhea by the tablet form of bismuth subsalicylate. Antimicrob Agents Chemother. 1986;29:625\u2013627.","journal-title":"Antimicrob Agents Chemother"},{"key":"6509_CR25","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jama.1987.03390100085031","volume":"257","author":"HL Dupont","year":"1987","unstructured":"Dupont HL, Ericsson CD, Johnson PC, et al. Preventing traveler\u2019s diarrhea by the tablet formulation of bismuth subsalicylate. JAMA. 1987;257:1347\u20131350.","journal-title":"JAMA"},{"key":"6509_CR26","first-page":"333","volume":"41","author":"H Sun","year":"2004","unstructured":"Sun H, Zhang L, Szeto KY. Bismuth in medicine. Met Ions Biol Syst. 2004;41:333\u2013378.","journal-title":"Met Ions Biol Syst"},{"key":"6509_CR27","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4155\/fmc.12.95","volume":"4","author":"JA Salvador","year":"2012","unstructured":"Salvador JA, Figueiredo SA, Pinto RM, Silvestre SM. Bismuth compounds in medicinal chemistry. Future Med Chem. 2012;4:1495\u20131523.","journal-title":"Future Med Chem"},{"key":"6509_CR28","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jama.1986.03370060071021","volume":"255","author":"PC Johnson","year":"1986","unstructured":"Johnson PC, Ericsson CD, Dupont HL, et al. Comparison of loperamide with bismuth subsalicylate for the treatment of acute travelers\u2019 diarrhea. JAMA. 1986;255:757\u2013760.","journal-title":"JAMA."},{"key":"6509_CR29","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0016-5085(19)31771-8","volume":"73","author":"HL DuPont","year":"1977","unstructured":"DuPont HL, Sullivan P, Pickering LK, et al. Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology. 1977;73:715\u2013718.","journal-title":"Gastroenterology"},{"key":"6509_CR30","doi-asserted-by":"crossref","unstructured":"Sun H, Zhang L, Szeto KY. Bismuth in medicine. In: Metal ions in biological systems, metal ions and their complexes in medication. Marcel Dekker; New York. 2004; Volume 41, pp. 333\u2013378.","DOI":"10.1201\/9780203913703.ch11"},{"key":"6509_CR31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1469-0691.2011.03571.x","volume":"18","author":"SM McGlone","year":"2012","unstructured":"McGlone SM, Bailey RR, Zimmer SM, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18:282\u2013289.","journal-title":"Clin Microbiol Infect"},{"key":"6509_CR32","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/jtm\/taw102","volume":"24","author":"Y Doi","year":"2017","unstructured":"Doi Y, Iovleva A, Bonomo RA. The ecology of extended-spectrum \u03b2-lactamases (ESBLs) in the developed world. J Travel Med. 2017;24:S44\u2013S51.","journal-title":"J Travel Med."},{"key":"6509_CR33","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/jtm\/taw101","volume":"24","author":"P Woerther","year":"2017","unstructured":"Woerther P, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterbacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24:S29\u2013S34.","journal-title":"J Travel Med."},{"key":"6509_CR34","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/jtm\/tax040","volume":"24","author":"HL DuPont","year":"2017","unstructured":"DuPont HL, Steffen R. Use of antimicrobial agents for treatment and prevention of travellers\u2019 diarrhea in the face of enhanced risk of transient fecal carriage of multi-drug resistant enterobacteriaceae: setting the stage for consensus recommendations. J Travel Med. 2017;24:S57\u2013S62.","journal-title":"J Travel Med."},{"key":"6509_CR35","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"RC Owens","year":"2008","unstructured":"Owens RC, Donskey CJ, Gaynes RP, et al. Antimicrobial risk factors for Clostridium difficile infection. Clin Infect Dis. 2008;46:S19\u2013S31.","journal-title":"Clin Infect Dis"},{"key":"6509_CR36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/136.5.693","volume":"136","author":"CD Ericsson","year":"1997","unstructured":"Ericsson CD, Evans DG, DuPont HL, et al. Bismuth subsalicylate inhibits crude toxins of Escherichia coli and Vibrio cholera. J Infect Dis. 1997;136:693\u2013696.","journal-title":"J Infect Dis"},{"key":"6509_CR37","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/clinids\/12.Supplement_1.S16","volume":"12","author":"CD Ericsson","year":"1990","unstructured":"Ericsson CD, Tannenbaum C, Charles TT. Antisecretory and antiinflammatory properties of bismuth subsalicylate. Rev Infect Dis. 1990;12:S16\u2013S20.","journal-title":"Rev Infect Dis"},{"key":"6509_CR38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0016-5085(83)80066-3","volume":"85","author":"DY Graham","year":"1983","unstructured":"Graham DY, Estes MK, Gentry LO. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology. 1983;85:1017\u20131022.","journal-title":"Gastroenterology"},{"key":"6509_CR39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1542\/peds.87.1.18","volume":"87","author":"H Soriano-Brucher","year":"1991","unstructured":"Soriano-Brucher H, Avendano P, O\u2019Ryan M, et al. Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics. 1991;87:18\u201327.","journal-title":"Pediatrics"},{"key":"6509_CR40","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/infdis\/157.5.1008","volume":"157","author":"R Steffen","year":"1988","unstructured":"Steffen R, Mathewson JJ, Ericsson CD, Dupont HL. Travelers\u2019 diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy. J Infect Dis. 1988;157:1008\u20131013.","journal-title":"J Infect Dis."},{"key":"6509_CR41","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/clinids\/12.Supplement_1.S24","volume":"12","author":"R Le\u00f3n-Bar\u00faa","year":"1990","unstructured":"Le\u00f3n-Bar\u00faa R, Tello R, Morante MC, et al. In vitro and in vivo effects of three bismuth compounds on fermentation by colonic bacteria. Rev Infect Dis. 1990;12:S24\u2013S29.","journal-title":"Rev Infect Dis."},{"key":"6509_CR42","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.cgh.2013.03.037","volume":"11","author":"J Antikainen","year":"2013","unstructured":"Antikainen J, Kantele A, Pakkanen SH, et al. A quantitative polymerase chain reaction assay for rapid detection of 9 pathogens directly from stools of travelers with diarrhea. Clin Gastroenterol Hepatol. 2013;11:1300\u20131307. e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6509_CR43","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1128\/JCM.00809-13","volume":"51","author":"M Koziel","year":"2013","unstructured":"Koziel M, Kiely R, Blake L, et al. Improved detection of bacterial pathogens in patients presenting with gastroenteritis by use of the EntericBio real-time Gastro Panel I assay. J Clin Microbiol. 2013;51:2679\u20132685.","journal-title":"J Clin Microbiol"},{"key":"6509_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/JCM.05416-11","volume":"50","author":"J Liu","year":"2012","unstructured":"Liu J, Gratz J, Maro A, et al. Simultaneous detection of six diarrhea-causing bacterial pathogens with an in-house PCR-luminex assay. J Clin Microbiol. 2012;50:98\u2013103.","journal-title":"J Clin Microbiol"},{"key":"6509_CR45","unstructured":"Bowen A, Agboatwallam, Pitz AM, et al. Bismuth subsalicylate reduces antimicrobial use among adult diarrhea patients in Pakistan: a randomized placebo controlled, triple masked clinical trial. Abstract (#1202) presented at the American Society of Tropical Medicine and Hygiene. 65th Annual Meeting 2016 Atlanta, GA, USA."},{"key":"6509_CR46","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/clinids\/12.Supplement_1.S3","volume":"12","author":"DW Bierer","year":"1990","unstructured":"Bierer DW. Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis. 1990;12:S3\u2013S8.","journal-title":"Rev Infect Dis"},{"key":"6509_CR47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0002-9343(83)90239-5","volume":"14","author":"AT Proudfoot","year":"1983","unstructured":"Proudfoot AT. Toxicity of Salicylates. Am J Med. 1983;14:99\u2013103.","journal-title":"Am J Med."},{"key":"6509_CR48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/096032719501400405","volume":"14","author":"LA Noach","year":"1995","unstructured":"Noach LA, Eekhof JL, Bour LJ, et al. Bismuth salts and neurotoxicity. A randomised, single-blind and controlled study. Hum Exp Toxicol. 1995;14:349\u2013355.","journal-title":"Hum Exp Toxicol"},{"key":"6509_CR49","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00007611-199409000-00001","volume":"87","author":"RJ Thomas","year":"1994","unstructured":"Thomas RJ. Neurotoxicity of antibacterial therapy. South Med J. 1994;87:869\u2013874.","journal-title":"South Med J"},{"key":"6509_CR50","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3810\/pgm.2009.07.2041","volume":"121","author":"BL Pearlman","year":"2009","unstructured":"Pearlman BL, Gambhir R. Salicylate intoxication: a clinical review. Postgrad Med. 2009;121:162\u2013168.","journal-title":"Postgrad Med"},{"key":"6509_CR51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00365529209000083","volume":"27","author":"B Dresow","year":"1992","unstructured":"Dresow B, Fischer R, Gabbe EE, et al. Bismuth absorption from bi-205-labeled pharmaceutical bismuth compounds used in the treatment of peptic-ulcer disease. Scand J Gastroenterol. 1992;27:333\u2013336.","journal-title":"Scand J Gastroenterol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-020-06509-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06509-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T03:31:42Z","timestamp":1667705502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-020-06509-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,8]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["6509"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06509-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,8]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Jose M. Brum MD, Roger D. Gibb PhD, David L. Ramsey MS, and Guhan Balan PhD are currently full-time employees of the Procter & Gamble Company. All remaining authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}